Sunday, May 12, 2002
17:30 19:15 (Auditorium 1)
New Options in the Treatment of Osteoporosis
Sponsors: Roche, GlaxoSmithKline
Co-chairs: D. Reid and G. Russell
An introduction to Ibandronate: Putting potency to work
Ibandronate: Taking oral bisphosphonates beyond daily and weekly dosing
Ibandronate i.v. bolus injection: Convenient form, novel regimen, lessons learned?
Turning to the future: The role of modeling and simulation?
Implications for less frequent dosing